Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

Pharmatica image of a Pharmaceutical research laboratory illustrating Good Laboratory Practice, controlled experiments, documentation, and data integrity in preclinical R&D.

Preclinical Development Biomedical R&D Pharma Policy

Good Laboratory Practice Always Sets the R&D Standard

Nicole Dale

Pharmatica image representing the AlphaGenome Atlas genomic AI map with single-nucleotide variant prediction across the human genome.

AI Drug Discovery AI & Machine Learning Research Informatics

AlphaGenome Atlas: Mapping Every Possible DNA Variant

Nicole Dale

Pharmatica image showing planning for FDA Expedited IND Pilot application to support faster preparation for first-in-human clinical trials.

Regulatory Pathways Regulatory Strategy Clinical Trial Regulation

FDA Expedited IND Pilot Targets Faster First-In-Human Trials

Nicole Dale

Pharmatica close-up image of a young child wearing a white T-shirt with a Rare Disease Day badge, seated in a bright clinical home environment with red medical devices in the background, representing rare disease care, patient independence, and humanitarian medical technology.

CDRH Rare Disease Impact Initiative Sets New FDA Focus

Pharmatica image of an ADC manufacturing facility showing antibody-drug conjugate drug product production and pharmaceutical processing equipment.

More Than Conjugation: ADC Manufacturing

Pharmatica GLP-1 obesity clinical development visual showing metabolic therapy, clinical research, and evidence generation.

GLP-1 Obesity Evidence Is Changing Clinical Development

Pharmatica editorial close‑up of FDA regulatory submission materials for diabetes devices, featuring a Libre glucose sensor, red insulin pen, and red office stamps and pens on a beige folder labeled, ‘U.S. Food & Drug Administration (FDA) – Regulatory Submission Diabetes Division,’ representing medical‑device approval and diabetes‑management technology.

Libre Duo FDA Authorisation Through De Novo Pathway

Explore All Insights

Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.

Nicole Dale

Why Precision Alone Isn't Enough in Oncology Drug Discovery

Precision alone isn’t enough in oncology drug discovery. See why execution, biomarkers, and trial design determine scalable success in precision medicine.

Nicole Dale

Select the Right Data Collection Method for Real-World Evidence

Choosing the wrong RWE data source undermines your regulatory strategy. This framework helps pharma leaders select the right real-world data collection method based on your programme’s research question.

Nicole Dale

Drug Discovery and Pharmacoinformatics in 2026

Pharmacoinformatics is redefining drug discovery strategy. This analysis covers the AI platforms, molecular design tools, and regulatory frameworks shaping R&D pipelines in 2026.

Nicole Dale

Seven Ways AI Is Solving Pharmaceutical Supply Chain Problems

AI is tackling the pharmaceutical supply chain's most persistent problems, from demand forecasting to counterfeit detection. See the top 7 ways AI is improving supply chain resiliency.

Nicole Dale

Decentralised Clinical Trials: Balance Innovation and Integrity

Decentralised clinical trials expand access and reduce patient burden. Learn how sponsors balance innovation in DCT design, data integrity, and regulatory compliance.

Nicole Dale

What 13 Years of Data Shows About Drug Innovation in Psychiatry

From 2012 through 2024, the FDA only approved 22 drugs for the treatment of psychiatric conditions. Pharma R&D teams must rethink development strategies to unstall drug innovation in psychiatry

Nicole Dale

What Pharma R&D Tech Investment Committees Actually Fund

What do pharma R&D tech investment committees really fund? Learn how workflow fit, enterprise pull, and strategic relevance drive adoption.

Nicole Dale

Modern Drug Discovery Challenges Demand a New Pharma Paradigm

Explore the biggest drug discovery challenges facing pharma today, from translational gaps to AI integration, and why a new pharma paradigm is needed.

Nicole Dale

Preclinical vs Clinical Research Strategy for Drug Development

Explore the critical differences between preclinical vs clinical research, and how closing the translation gap can reduce drug development attrition and improve R&D decision-making.

Nicole Dale

Why the U.S. Medicine Supply Chain Is One Shortage Away from Crisis

The USP's 2025 Vulnerable Medicines List flags 100 drugs at high risk. Here is what to do to build pharma supply chain resilience.

Nicole Dale

Strategic Pharma Intelligence Drives Better Decisions in Life Sciences

Strategic pharma intelligence concept featuring Pharmatica branding, molecular structures, global business leaders in discussion, and pharmaceutical innovation imagery, representing data-driven decision-making, industry analysis, and executive strategy in the life sciences sector.

Find out why strategic pharma intelligence is needed to connect insights and to guide confident decision-making across the drug development lifecycle.

Nicole Dale

Close the Drug Discovery Loop by Leveraging the DMTA Cycle

Pharmatica branded pharmaceutical research image featuring a laboratory scientist using a pipette, overlaid with molecular network graphics representing drug discovery, pharmaceutical R&D, and scientific innovation from integrated DMTA cycles.

The DMTA cycle is the engine of modern pharma R&D. Learn how integrated DMTA workflows reduce early-stage attrition and compress drug discovery timelines.

Topic